INTIMATION OF CLOSURE OF TRADING WINDOW FOR THE QUARTER ENDED 31ST MARCH 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Beryl Drugs Ltd has informed the stock exchanges that its trading window for dealing in company shares has been closed with effect from the end of the quarter ended 31st March 2026. This is a mandatory compliance measure under SEBI's Insider Trading (Prohibition) Regulations, which prohibits insiders — including directors, key managerial personnel, employees and their immediate relatives — from buying or selling the company's shares while in possession of unpublished price-sensitive information. The window will typically reopen 48 hours after the audited financial results for the quarter and full year are officially announced. No specific financial figures or corporate action details are disclosed in this intimation.
This is a routine regulatory compliance filing with no direct impact on share price or shareholder value. It simply signals that the company is preparing to declare its Q4 and FY26 financial results shortly.